 |
 |
 |
| Reinventing Therapeutics Through Chemical Genomics | |
 |
|
| top > | |
Reinventing Therapeutics Through Chemical Genomics |
|
|
Aphoenix, Inc. is a chemical genomics company based in Tokyo, Japan. Our technology platform is a "reverse targeting," approach of small molecules. Using its proprietary affinity chromatographic techniques, we exploit drugs which lack known mechanisms of action as probes for discovering valid and druggable targets, and then develop such compounds against validated targets. +Overview |
|
|
Latest News |
|
| April, 2010 : | Aphoenix signed RecepFishTM Agreement with Western States Biopharmaceuticals using FG beads | |
| March, 2010 : | A Primary Target of Thalidomide Teratogenicity was identified using FG beads | |
| September, 2009 : | Aphoenix lanuched one page FG Beads Catalog as an advertisement on nature chemical biology, September 2009 - Vol 5 No 9. | |
| +and more... |